Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v2.4.1.9
CONSOLIDATED BALANCE SHEETS (USD $)
Mar. 31, 2015
Dec. 31, 2014
Current assets    
Cash $ 25,016us-gaap_Cash $ 623us-gaap_Cash
Total current assets 25,016us-gaap_AssetsCurrent 623us-gaap_AssetsCurrent
Property and euipment - net 270us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment 454us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment
Total Assets 25,286us-gaap_Assets 1,077us-gaap_Assets
Current liabilities    
Accounts payable 517,699us-gaap_AccountsPayableCurrent 484,260us-gaap_AccountsPayableCurrent
Accrued interest payable 445,736us-gaap_InterestPayableCurrent 407,684us-gaap_InterestPayableCurrent
Notes payable - current - related parties 697,225us-gaap_NotesPayableRelatedPartiesClassifiedCurrent 697,225us-gaap_NotesPayableRelatedPartiesClassifiedCurrent
Notes payable - current, net 895,814us-gaap_NotesPayableCurrent 871,694us-gaap_NotesPayableCurrent
Notes payable - derivitive liability payable 0us-gaap_DerivativeLiabilities 25,456us-gaap_DerivativeLiabilities
Stock subscriptions received 28,067IMLE_StockSubscriptionsReceived 28,067IMLE_StockSubscriptionsReceived
Related party payables 325,765us-gaap_AccountsPayableRelatedPartiesCurrent 296,265us-gaap_AccountsPayableRelatedPartiesCurrent
Other payables 241,922us-gaap_AccountsPayableOtherCurrent 241,922us-gaap_AccountsPayableOtherCurrent
Total current liabilities 3,152,228us-gaap_LiabilitiesCurrent 3,052,573us-gaap_LiabilitiesCurrent
Notes payable - related parties 43,298us-gaap_NotesPayableRelatedPartiesNoncurrent 43,298us-gaap_NotesPayableRelatedPartiesNoncurrent
Total Liabilities 3,195,526us-gaap_Liabilities 3,095,871us-gaap_Liabilities
Stockholders' Deficit    
Common stock, $.00001 par value; 100,000,000 shares authorized; 58,416,660 and 58,416,660 shares issued and outstanding as of March 31. 2015 and December 31 2014, respectively 585us-gaap_CommonStockValue 585us-gaap_CommonStockValue
Additional paid in capital 12,760,347us-gaap_AdditionalPaidInCapital 12,716,630us-gaap_AdditionalPaidInCapital
Accumulated deficit (15,895,451)us-gaap_RetainedEarningsAccumulatedDeficit (15,777,222)us-gaap_RetainedEarningsAccumulatedDeficit
Total Transbiotec, Inc. stockholders' deficit (3,134,519)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest (3,060,007)us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Noncontrolling interest (35,721)us-gaap_MinorityInterest (34,787)us-gaap_MinorityInterest
Total Stockholders' Deficit (3,170,240)us-gaap_StockholdersEquity (3,094,794)us-gaap_StockholdersEquity
Total Liabilities and Stockholders' Deficit $ 25,286us-gaap_LiabilitiesAndStockholdersEquity $ 1,077us-gaap_LiabilitiesAndStockholdersEquity